Evidence map›Paper›PMID 23200759›Full record

ArticleHuman immunology2013

Identification of the MICA*070 allele by sequencing and phasing.

D Moran, S Morishima, M Malkki, E W Petersdorf

Abstract read
In one paragraph

Article in Human immunology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. High HLA-DP Expression and Graft-versus-Host Disease.The New England journal of medicine · 2015
    Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

D MoranDivision of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
S Morishima
M Malkki
E W Petersdorf

Funding

VIRUS-MEDIATED MYELOSUPPRESSIONP01CA018029 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Geoffrey Roger HILL · 1985 to 2026
$128.4M
Clinical Significance of MHC Haplotypes in Hematopoietic Cell TransplantationR01CA100019 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI PETERSDORF, EFFIE W · 2003 to 2025
$9.1M
NCI NIH HHS CA100019NCI NIH HHS CA18029NCI NIH HHS P01 CA018029NCI NIH HHS R01 CA100019
6 · The paper itself

Abstract

A novel MICA allele, MICA*070, was defined by sequencing. The new allele differs from the MICA*008:04 sequence in exon 2, encoding a C instead of G corresponding to cDNA nucleotide position 183. This nucleotide substitution is predicted to encode serine instead of arginine at residue 38 of the α1 domain of the MICA molecule.

Indexed as

Polymorphism, GeneticAllelesBase SequenceExonsHistocompatibility Antigens Class IHumansMolecular Sequence DataPolymerase Chain ReactionReproducibility of ResultsSequence Analysis, DNASequence Homology, Nucleic AcidHistocompatibility Antigens Class IMHC class I-related chain A

Identifiers

PMID23200759
PMCPMC3628399

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.